|
|
|
|
|
|
About Reyoung
Reyoung Pharmaceutical Co., Ltd. was founded in 1966, with a total asset of USD500 million and more than 4000 staff. It’s the first manufacturer of powder for injection in Shandong province and is a Singapore-listed company since Sep. 2005. Reyoung is a State Focused High & New Tech. Enterprise, Backbone Enterprise of the National Biopharmaceutical Industry, National Abiding by Contracts and Keeping Promises Enterprise and Star Enterprise of China patent in Shandong Province with provincial-level enterprise technology centers, engineering technology research center and national post-doctoral research station.
Production Line
Reyoung now has more than 20 workshops including powder for injection, raw materials, solid products, and traditional medicines, and small volume injection, and so on, and all workshops have passed the GMP certification. Reyoung is also an ISO9001, ISO14001 and OHS18001 enterprise and has passed the international management certification system of quality, circumstances and occupational health and safety. The production capacity of powder for injection (lyophilized powder for injection) is 2.0 billions, small liquid injection is 200 millions, tablets is 4 billions, capsules is 2 billions, granules is 100 millions, suppository is 10 millions, and raw materials is 2000 tons.
International Market
The import and export department of our company was founded in 1997, and after 14 years of development, depending on the strict GMP and high quality products. Reyoung has gained the GMP certification of Colombia, Ethiopia, and Uganda and so on and the products have been sold to more than twenty countries like Hong Kong, Colombia ,Georgia ,Turkmenistan ,Bolivia ,Chile, Peru, Ethiopia , Venezuela , and so on Especially our product Amoxicillin sodium and Clavulanate Potassium for injection (Trade Name: LIDINGSHA) was the first national powder for injection that entered Hong Kong, at present, LIDINGSHA market share is the first of the government hospital of Hong Kong. The export income reach to USD 30 millions of 2010 and estimate reach USD 35 millions in 2011. |
|
|
| preparation , capsule , tablets ,powder for injection(lyophilized powder for injection ), small liquid injection, granules, suppository ,raw materials, Antibiotics , penicillin pharmaceutical, cephalosporin, |
|
|
| Company : |
|
| Email: |
Contact us |
| URL: |
********
********
|
| Phone: |
*********
|
| Fax : |
*********
|
| Country : |
China |
| Address : |
*********
|
|
|
|
|
|
